144 related articles for article (PubMed ID: 10849732)
1. Natural substrates of dipeptidyl peptidase IV.
De Meester I; Durinx C; Bal G; Proost P; Struyf S; Goossens F; Augustyns K; Scharpé S
Adv Exp Med Biol; 2000; 477():67-87. PubMed ID: 10849732
[No Abstract] [Full Text] [Related]
2. Post-secretory processing of regulatory peptides: the pancreatic polypeptide family as a model example.
Medeiros MS; Turner AJ
Biochimie; 1994; 76(3-4):283-7. PubMed ID: 7819336
[TBL] [Abstract][Full Text] [Related]
3. Proteolytic processing of neuropeptide Y and peptide YY by dipeptidyl peptidase IV.
Mentlein R; Dahms P; Grandt D; Krüger R
Regul Pept; 1993 Dec; 49(2):133-44. PubMed ID: 7907802
[TBL] [Abstract][Full Text] [Related]
4. Neuropeptide Y, B-type natriuretic peptide, substance P and peptide YY are novel substrates of fibroblast activation protein-α.
Keane FM; Nadvi NA; Yao TW; Gorrell MD
FEBS J; 2011 Apr; 278(8):1316-32. PubMed ID: 21314817
[TBL] [Abstract][Full Text] [Related]
5. Dipeptidyl peptidase IV substrates. An update on in vitro peptide hydrolysis by human DPPIV.
de Meester I; Lambeir AM; Proost P; Scharpé S
Adv Exp Med Biol; 2003; 524():3-17. PubMed ID: 12675218
[No Abstract] [Full Text] [Related]
6. Selective inhibition of dipeptidyl peptidase 4 by targeting a substrate-specific secondary binding site.
Kühn-Wache K; Bär JW; Hoffmann T; Wolf R; Rahfeld JU; Demuth HU
Biol Chem; 2011 Mar; 392(3):223-31. PubMed ID: 21284559
[TBL] [Abstract][Full Text] [Related]
7. A kinetic study of glucagon-like peptide-1 and glucagon-like peptide-2 truncation by dipeptidyl peptidase IV, in vitro.
Lambeir AM; Proost P; Scharpé S; De Meester I
Biochem Pharmacol; 2002 Dec; 64(12):1753-6. PubMed ID: 12445864
[TBL] [Abstract][Full Text] [Related]
8. The N-terminal domain of chromogranin A (CgA1-40) interacts with monolayers of membrane lipids of fungal and mammalian compositions.
Maget-Dana R; Metz-Boutigue MH; Helle KB
Ann N Y Acad Sci; 2002 Oct; 971():352-4. PubMed ID: 12438150
[No Abstract] [Full Text] [Related]
9. Characterization of the peptide binding requirements for the cloned human pancreatic polypeptide-preferring receptor.
Gehlert DR; Schober DA; Beavers L; Gadski R; Hoffman JA; Smiley DL; Chance RE; Lundell I; Larhammar D
Mol Pharmacol; 1996 Jul; 50(1):112-8. PubMed ID: 8700103
[TBL] [Abstract][Full Text] [Related]
10. Neutral endopeptidase 24.11 and dipeptidyl peptidase IV are both involved in regulating the metabolic stability of glucagon-like peptide-1 in vivo.
Plamboeck A; Holst JJ; Carr RD; Deacon CF
Adv Exp Med Biol; 2003; 524():303-12. PubMed ID: 12675252
[No Abstract] [Full Text] [Related]
11. The specificity of DP IV for natural substrates is peptide structure determined.
Kühn-Wache K; Hoffmann T; Manhart S; Brandt W; Demuth HU
Adv Exp Med Biol; 2003; 524():57-63. PubMed ID: 12675223
[No Abstract] [Full Text] [Related]
12. Dipeptidyl peptidase IV regulates proliferation of preglomerular vascular smooth muscle and mesangial cells.
Jackson EK; Kochanek SJ; Gillespie DG
Hypertension; 2012 Sep; 60(3):757-64. PubMed ID: 22802229
[TBL] [Abstract][Full Text] [Related]
13. Dipeptidyl peptidases 8 and 9: specificity and molecular characterization compared with dipeptidyl peptidase IV.
Bjelke JR; Christensen J; Nielsen PF; Branner S; Kanstrup AB; Wagtmann N; Rasmussen HB
Biochem J; 2006 Jun; 396(2):391-9. PubMed ID: 16475979
[TBL] [Abstract][Full Text] [Related]
14. Characterisation of human dipeptidyl peptidase IV expressed in Pichia pastoris. A structural and mechanistic comparison between the recombinant human and the purified porcine enzyme.
Bär J; Weber A; Hoffmann T; Stork J; Wermann M; Wagner L; Aust S; Gerhartz B; Demuth HU
Biol Chem; 2003 Dec; 384(12):1553-63. PubMed ID: 14719797
[TBL] [Abstract][Full Text] [Related]
15. Structural and biological characterization of chromofungin, the antifungal chromogranin A (47-66)-derived peptide.
Lugardon K; Chasserot-Golaz S; Kieffer AE; Maget-Dana R; Nullans G; Kieffer B; Aunis D; Metz-Boutigue MH
Ann N Y Acad Sci; 2002 Oct; 971():359-61. PubMed ID: 12438152
[TBL] [Abstract][Full Text] [Related]
16. Structural similarities of micelle-bound peptide YY (PYY) and neuropeptide Y (NPY) are related to their affinity profiles at the Y receptors.
Lerch M; Mayrhofer M; Zerbe O
J Mol Biol; 2004 Jun; 339(5):1153-68. PubMed ID: 15178255
[TBL] [Abstract][Full Text] [Related]
17. Presence and release of SR-17 (chromogranin B(586-602)) in the porcine splenic nerve and its enzymatic degradation by CD26/dipeptidyl peptidase IV.
Depreitere J; Durinx C; Wang Z; Coen E; Lambeir AM; Scharpé S; De Potter W; Nouwen EJ
Regul Pept; 2002 Jun; 106(1-3):71-9. PubMed ID: 12047913
[TBL] [Abstract][Full Text] [Related]
18. Antibacterial and antifungal peptides derived from chromogranins and proenkephalin-A. From structural to biological aspects.
Metz-Boutigue MH; Lugardon K; Goumon Y; Raffner R; Strub JM; Aunis D
Adv Exp Med Biol; 2000; 482():299-315. PubMed ID: 11192590
[No Abstract] [Full Text] [Related]
19. Some peptide-like colocalizations in endocrine cells of the pyloric caeca and the intestine of Oncorhynchus mykiss (Teleostei).
Beorlegui C; Martínez A; Sesma P
Cell Tissue Res; 1992 Aug; 269(2):353-7. PubMed ID: 1423502
[TBL] [Abstract][Full Text] [Related]
20. Processing of pro-colipase and trypsinogen by pancreatic dipeptidyl peptidase IV.
Heymann E; Mentlein R; Nausch I; Erlanson-Albertsson C; Yoshimoto T; Feller AC
Biomed Biochim Acta; 1986; 45(5):575-84. PubMed ID: 2875713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
